Page 379 - Read Online
P. 379

Page 10 of 10                                  Reverberi et al. Mini-invasive Surg 2020;4:43  I  http://dx.doi.org/10.20517/2574-1225.2020.33

                   cancer: a systematic review. Thorac Cancer 2018;9:337-47.
               34.   Scotti V, Bruni A, Francolini G, Perna M, Vasilyeva P, et al. Stereotactic ablative radiotherapy as an alternative to lobectomy in patients
                   with medically operable stage I NSCLC: a retrospective, multicenter analysis. Clin Lung Cancer 2019;20:e53-61.
               35.   Robinson CG, DeWees TA, El Naqa IM, Creach KM, Olsen JR, et al. Patterns of failure after stereotactic body radiation therapy or lobar
                   resection for clinical stage I non-small-cell lung cancer. J Thorac Oncol 2013;8:192-201.
               36.   Chen H, Laba JM, Boldt RG, Goodman CD, Palma DA, et al. Stereotactic ablative radiation therapy versus surgery in early lung cancer:
                   a meta-analysis of propensity score studies. Int J Radiat Oncol Biol Phys 2018;101:186-94.
               37.   Khakwani A, Harden S, Beckett P, Baldwin D, Navani N, et al. Post- treatment survival difference between lobectomy and stereotactic
                   ablative radiotherapy in stage I non- small cell lung cancer in England. Thorax 2020;75:237-43.
               38.   Cao C, Wang D, Chung C, Tian D, Rimner A, et al. A systematic review and meta-analysis of stereotactic body radiation therapy versus
                   surgery for patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 2019;157:362-73.e8.
               39.   Ezer N, Veluswamy RR, Mhango G, Rosenzweig KE, Powell CA, et al. Outcomes after stereotactic body radiotherapy versus limited
                   resection in older patients with early-stage lung cancer. J Thorac Oncol 2015;10:1201-6.
               40.   Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, et al. Outcomes after stereotactic lung radiotherapy or wedge resection
                   for stage I non-small-cell lung cancer. J Clin Oncol 2010;28:928-35.
               41.   Wu J, Bai HX, Chan L, Su C, Zhang PJ, et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early
                   stage non-small cell lung cancer: a national cancer database study. J Thorac Cardiovasc Surg 2019; doi: 10.1016/j.jtcvs.2019.11.132.
               42.   Yerokun BA, Yang CJ, Gulack BC, Li X, Mulvihill MS, et al. A national analysis of wedge resection versus stereotactic body radiation
                   therapy for stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2017;154:675-86.e4.
   374   375   376   377   378   379   380   381   382   383   384